Showing results (221-230 of 1,630) with videos related to
Sort By:
Pageof 163
Clinical and Translational Medicine|March 27, 2023
The therapeutic potential of targeting minimal residual disease in melanomaRiyaben P Patel, Pretashini M Somasundram, Lorey K Smith, et al.Clinical and Translational Medicine|June 9, 2020
Prostate-specific antigen modulates the osteogenic differentiation of MSCs via the cadherin 11-Akt axisLongxiang Wu, Shiqi Xiang, Xiheng Hu, et al.Clinical and Translational Medicine|June 9, 2020
T-cell activation and immune memory enhancement induced by irreversible electroporation in pancreatic cancerChaobin He, Xin Huang, Yu Zhang, et al.Clinical and Translational Medicine|June 9, 2020
COVID-19 critical illness pathophysiology driven by diffuse pulmonary thrombi and pulmonary endothelial dysfunction responsive to thrombolysisHooman D Poor, Corey E Ventetuolo, Thomas Tolbert, et al.Clinical and Translational Medicine|August 30, 2021
LncRNA nuclear-enriched abundant transcript 1 shuttled by prostate cancer cells-secreted exosomes initiates osteoblastic phenotypes in the bone metastatic microenvironment via miR-205-5p/runt-related transcription factor 2/splicing factor proline- and glutamine-rich/polypyrimidine tract-binding protein 2 axisChengqiang Mo, Bin Huang, Jintao Zhuang, et al.Clinical and Translational Medicine|August 30, 2021
Single-cell transcriptomes reveal heterogeneity of high-grade serous ovarian carcinomaQian Hao, Jiajia Li, Qinghua Zhang, et al.Clinical and Translational Medicine|August 30, 2021
Oncogenic PAX6 elicits CDK4/6 inhibitor resistance by epigenetically inactivating the LATS2-Hippo signaling pathwayYi Zhang, Long-Jun He, Lin-Lin Huang, et al.Clinical and Translational Medicine|August 30, 2021
Potential biomarkers and targets of mitochondrial dynamicsLiyang Li, Ruixue Qi, Linlin Zhang, et al.Clinical and Translational Medicine|February 5, 2023
YAP/TAZ activation predicts clinical outcomes in mesothelioma and is conserved in in vitro model of driver mutationsRichard Cunningham, Siyang Jia, Krishna Purohit, et al.Clinical and Translational Medicine|March 1, 2023
Angiotensin receptor blockers retard the progression and fibrosis via inhibiting the viability of AGTR1+ CAFs in intrahepatic cholangiocarcinomaJian-Hui Li, Xiao Wu, Xuhao Ni, et al.Pageof 163